Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Patricia Harkins & Richard Conway. (2022) Giant cell arteritis: what is new in the preclinical and early clinical development pipeline?. Expert Opinion on Investigational Drugs 31:9, pages 921-932.
Read now
Read now
Robert Harrington, Shamma Ahmad Al Nokhatha & Richard Conway. (2021) Biologic Therapies for Giant Cell Arteritis. Biologics: Targets and Therapy 15, pages 17-29.
Read now
Read now
Alwin Sebastian, Alessandro Tomelleri & Bhaskar Dasgupta. (2021) Current and innovative therapeutic strategies for the treatment of giant cell arteritis. Expert Opinion on Orphan Drugs 9:5, pages 161-173.
Read now
Read now
Francesco Muratore, Nicolò Pipitone & Carlo Salvarani. (2017) Standard and biological treatment in large vessel vasculitis: guidelines and current approaches. Expert Review of Clinical Immunology 13:4, pages 345-360.
Read now
Read now
Angelina Espino Barros, Alec L. Amram, Angeline Mariani Derham, Stacy V. Smith & Andrew G. Lee. (2017) Management of ischemic optic neuropathies. Expert Review of Ophthalmology 12:2, pages 99-109.
Read now
Read now
Christian Dejaco, Christina Duftner, Bhaskar Dasgupta, Eric L Matteson & Michael Schirmer. (2011) Polymyalgia Rheumatica and Giant Cell Arteritis: Management of Two Diseases of the Elderly. Aging Health 7:4, pages 633-645.
Read now
Read now
Articles from other publishers (49)
Daniela Opriș-Belinski, Claudia Oana Cobilinschi & Ioana Săulescu. (2024) Current Perspectives in Giant Cell Arteritis: Can We Better Connect Pathogenesis and Treatment?. Medicina 60:3, pages 400.
Crossref
Crossref
Elvis Hysa, Milena Bond, Lisa Ehlers, Dario Camellino, Louise Falzon, Christian Dejaco, Frank Buttgereit, Daniel Aletaha & Andreas Kerschbaumer. (2024) Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review. Rheumatology 63:2, pages 285-297.
Crossref
Crossref
Yasser El Miedany, Maha Elgaafary, Mathias Toth, Atef Abdel Azim, Deborah Palmer, Gillian Dolbear, Mohamed Hassan Abu-zaid, Dora Affam, Waleed Hassan, Bassant Elnady, Samar abdAlhamed Tabra & Sally Saber. (2023) Development of outcome measures for giant cell arteritis for use in clinical trials and standard practice. Clinical Rheumatology 42:11, pages 3049-3057.
Crossref
Crossref
Jason M. Springer & Tanaz A. Kermani. (2023) Recent advances in the treatment of giant cell arteritis. Best Practice & Research Clinical Rheumatology 37:1, pages 101830.
Crossref
Crossref
Imran Jivraj. (2023) Treatment of Giant Cell Arteritis. International Ophthalmology Clinics 63:2, pages 39-54.
Crossref
Crossref
Denes Szekeres & Bayan Al Othman. (2022) Current developments in the diagnosis and treatment of giant cell arteritis. Frontiers in Medicine 9.
Crossref
Crossref
Alexis Régent & Luc Mouthon. (2022) Treatment of Giant Cell Arteritis (GCA). Journal of Clinical Medicine 11:7, pages 1799.
Crossref
Crossref
Anne-Laure Gérard, Noémie Simon-Tillaux, Youri Yordanov, Patrice Cacoub, Florence Tubach, David Saadoun & Agnès Dechartres. (2021) Efficacy and safety of steroid-sparing treatments in giant cell arteritis according to the glucocorticoids tapering regimen: A systematic review and meta-analysis. European Journal of Internal Medicine 88, pages 96-103.
Crossref
Crossref
Elena Galli, Chiara Marvisi, Gilda Sandri, Carlo Umberto Manzini & Carlo Salvarani. (2021) The management of large vessel vasculitides. Beyond Rheumatology 3:1.
Crossref
Crossref
Andriko Palmowski & Frank Buttgereit. (2020) Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis. Current Rheumatology Reports 22:12.
Crossref
Crossref
J. H. Schirmer, P. M. Aries, K. Balzer, P. Berlit, T. A. Bley, F. Buttgereit, M. Czihal, C. Dechant, C. Dejaco, U. Garske, J. Henes, J. U. Holle, K. Holl-Ulrich, P. Lamprecht, B. Nölle, F. Moosig, J. Rech, K. Scheuermann, M. Schmalzing, W. A. Schmidt, M. Schneider, H. Schulze-Koops, N. Venhoff, P. M. Villiger, T. Witte, M. Zänker & B. Hellmich. (2020) S2k-Leitlinie: Management der GroßgefäßvaskulitidenS2k guidelines: management of large-vessel vasculitis. Zeitschrift für Rheumatologie 79:S3, pages 67-95.
Crossref
Crossref
Samuel Deshayes, Hubert de Boysson, Anaël Dumont, Denis Vivien, Alain Manrique & Achille Aouba. (2020) An overview of the perspectives on experimental models and new therapeutic targets in giant cell arteritis. Autoimmunity Reviews 19:10, pages 102636.
Crossref
Crossref
H. S. Lyons, V. Quick, A. J. Sinclair, S. Nagaraju & S. P. Mollan. (2019) A new era for giant cell arteritis. Eye 34:6, pages 1013-1026.
Crossref
Crossref
Sarah L Mackie, Christian Dejaco, Simone Appenzeller, Dario Camellino, Christina Duftner, Solange Gonzalez-Chiappe, Alfred Mahr, Chetan Mukhtyar, Gary Reynolds, Alexandre Wagner S de Souza, Elisabeth Brouwer, Marwan Bukhari, Frank Buttgereit, Dorothy Byrne, Maria C Cid, Marco Cimmino, Haner Direskeneli, Kate Gilbert, Tanaz A Kermani, Asad Khan, Peter Lanyon, Raashid Luqmani, Christian Mallen, Justin C Mason, Eric L Matteson, Peter A Merkel, Susan Mollan, Lorna Neill, Eoin O’ Sullivan, Maria Sandovici, Wolfgang A Schmidt, Richard Watts, Madeline Whitlock, Elaine Yacyshyn, Steven Ytterberg & Bhaskar Dasgupta. (2020) British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. Rheumatology 59:3, pages e1-e23.
Crossref
Crossref
Bernhard Hellmich, Ana Agueda, Sara Monti, Frank Buttgereit, Hubert de Boysson, Elisabeth Brouwer, Rebecca Cassie, Maria C Cid, Bhaskar Dasgupta, Christian Dejaco, Gulen Hatemi, Nicole Hollinger, Alfred Mahr, Susan P Mollan, Chetan Mukhtyar, Cristina Ponte, Carlo Salvarani, Rajappa Sivakumar, Xinping Tian, Gunnar Tomasson, Carl Turesson, Wolfgang Schmidt, Peter M Villiger, Richard Watts, Chris Young & Raashid Ahmed Luqmani. (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Annals of the Rheumatic Diseases 79:1, pages 19-30.
Crossref
Crossref
M. Samson, H. Greigert, T. Ghesquiere & B. Bonnotte. (2020) Artérite à cellules géantes : de la physiopathologie aux nouvelles cibles thérapeutiques. Bulletin de l'Académie Nationale de Médecine 204:1, pages 18-28.
Crossref
Crossref
Sara Monti, Ana F Águeda, Raashid Ahmed Luqmani, Frank Buttgereit, Maria Cid, Christian Dejaco, Alfred Mahr, Cristina Ponte, Carlo Salvarani, Wolfgang Schmidt & Bernhard Hellmich. (2019) Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis. RMD Open 5:2, pages e001003.
Crossref
Crossref
Maxime Samson, Hélène Greigert, Thibault Ghesquière & Bernard Bonnotte. (2019) Traitement de l’artérite à cellules géantes. La Presse Médicale 48:9, pages 968-979.
Crossref
Crossref
Alia Z. Al-Mousawi, Sam P. Gurney, Alice R. Lorenzi, Ute Pohl, Margaret Dayan & Susan P. Mollan. (2019) Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis. Ophthalmology and Therapy 8:2, pages 177-193.
Crossref
Crossref
Alexander Pfeil, Peter Oelzner & Peter Hellmann. (2019) The Treatment of Giant Cell Arteritis in Different Clinical Settings. Frontiers in Immunology 9.
Crossref
Crossref
Candice Low & Richard Conway. (2019) Current advances in the treatment of giant cell arteritis: the role of biologics. Therapeutic Advances in Musculoskeletal Disease 11, pages 1759720X1982722.
Crossref
Crossref
Jem V. Ninan, Susan Lester & Catherine L. Hill. (2018) Diagnosis and management of giant cell arteritis: an Asia‐Pacific perspective. International Journal of Rheumatic Diseases 22:S1, pages 28-40.
Crossref
Crossref
J. C. Henes, H. Schulze-Koops, M. Witt, H. P. Tony, F. Mueller, M. Grunke, M. Czihal, T. Dörner & F. Proft. (2017) Off-label-Biologikatherapie bei Patienten mit Großgefäßvaskulitiden und/oder Polymyalgia rheumaticaOff-label biological therapies in patients with large vessel vasculitis and/or polymyalgia rheumatica. Zeitschrift für Rheumatologie 77:1, pages 12-20.
Crossref
Crossref
Jem V. Ninan, Susan Lester & Catherine L. Hill. (2017) Giant cell arteritis: beyond temporal artery biopsy and steroids. Internal Medicine Journal 47:11, pages 1228-1240.
Crossref
Crossref
Imran Jivraj & M.A. Tamhankar. (2017) Newer Therapies for Giant Cell Arteritis. Advances in Ophthalmology and Optometry 2:1, pages 321-338.
Crossref
Crossref
P. M. Villiger. (2017) GroßgefäßvaskulitidenLarge vessel vasculitis. Zeitschrift für Rheumatologie 76:6, pages 509-523.
Crossref
Crossref
Cecilia Beatrice Chighizola, Voon H. Ong & Pier Luigi Meroni. (2016) The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review. Clinical Reviews in Allergy & Immunology 52:3, pages 401-423.
Crossref
Crossref
Durga Prasanna Misra, Aman Sharma, Tamilarasu Kadhiravan & Vir Singh Negi. (2017) A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis. Autoimmunity Reviews 16:2, pages 179-191.
Crossref
Crossref
Imran Jivraj & Madhura Tamhankar. (2017) The Treatment of Giant Cell Arteritis. Current Treatment Options in Neurology 19:1.
Crossref
Crossref
Tanaz A. Kermani, David Cuthbertson, Simon Carette, Gary S. Hoffman, Nader A. Khalidi, Curry L. Koening, Carol A. Langford, Kathleen McKinnon-Maksimowicz, Carol A. McAlear, Paul A. Monach, Philip Seo, Kenneth J. Warrington, Steven R. Ytterberg, Peter A. Merkel & Eric L. Matteson. (2016) The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis. The Journal of Rheumatology 43:6, pages 1078-1084.
Crossref
Crossref
Paul Renauer, Patrick Coit & Amr H. Sawalha. (2015) Epigenetics and Vasculitis: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 50:3, pages 357-366.
Crossref
Crossref
B. Bienvenu, K.H. Ly, M. Lambert, C. Agard, M. André, Y. Benhamou, B. Bonnotte, H. de Boysson, O. Espitia, G. Fau, A.-L. Fauchais, F. Galateau-Sallé, J. Haroche, E. Héron, F.-X. Lapébie, E. Liozon, L.B. Luong Nguyen, J. Magnant, A. Manrique, M. Matt, M. de Menthon, L. Mouthon, X. Puéchal, G. Pugnet, T. Quemeneur, A. Régent, D. Saadoun, M. Samson, D. Sène, P. Smets, C. Yelnik, L. Sailler & A. Mahr. (2016) Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA). La Revue de Médecine Interne 37:3, pages 154-165.
Crossref
Crossref
Eric L. Matteson, Frank Buttgereit, Christian Dejaco & Bhaskar Dasgupta. (2016) Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis. Rheumatic Disease Clinics of North America 42:1, pages 75-90.
Crossref
Crossref
Jem Ninan, Susan Lester & Catherine Hill. (2016) Giant cell arteritis. Best Practice & Research Clinical Rheumatology 30:1, pages 169-188.
Crossref
Crossref
Lorraine O'Neill, Cristina Ponte, Jan Sznajd, Anna P. Rodrigues, Benjamin Seeliger & Raashid A. Luqmani. (2015) Giant Cell Arteritis and Takayasu Arteritis: Are they a different spectrum of the same disease?. Indian Journal of Rheumatology 10, pages S11-S21.
Crossref
Crossref
Cristina Ponte, Ana Filipa Rodrigues, Lorraine O’Neill & Raashid Ahmed Luqmani. (2015) Giant cell arteritis: Current treatment and management. World Journal of Clinical Cases 3:6, pages 484.
Crossref
Crossref
Marlies C van der Goes, Johannes W Jacobs & Johannes W Bijlsma. (2014) The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects. Arthritis Research & Therapy 16:S2.
Crossref
Crossref
N Duru, M C van der Goes, J W G Jacobs, T Andrews, M Boers, F Buttgereit, N Caeyers, M Cutolo, S Halliday, J A P Da Silva, J R Kirwan, D Ray, J Rovensky, G Severijns, R Westhovens & J W J Bijlsma. (2013) EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases 72:12, pages 1905-1913.
Crossref
Crossref
T. Adizie, D. Christidis, C. Dharmapaliah, F. Borg & B. Dasgupta. (2012) Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series. International Journal of Clinical Practice 66:9, pages 906-909.
Crossref
Crossref
Ryan A. Scheurer, Andrew R. Harrison & Michael S. Lee. (2011) Treatment of Vision Loss in Giant Cell Arteritis. Current Treatment Options in Neurology 14:1, pages 84-92.
Crossref
Crossref
HANER DIRESKENELI, SIBEL Z. AYDIN, TANAZ A. KERMANI, ERIC L. MATTESON, MAARTEN BOERS, KAREN HERLYN, RAASHID A. LUQMANI, TUHINA NEOGI, PHILIP SEO, RAVI SUPPIAH, GUNNAR TOMASSON & PETER A. MERKEL. (2011) Development of Outcome Measures for Large-vessel Vasculitis for Use in Clinical Trials: Opportunities, Challenges, and Research Agenda. The Journal of Rheumatology 38:7, pages 1471-1479.
Crossref
Crossref
Sohan Singh HayrehSohan Singh Hayreh. 2011. Ischemic Optic Neuropathies. Ischemic Optic Neuropathies
227
264
.
E. Wipfler-Freißmuth, J. Loock, F. Moosig, C. Dejaco, C. Duftner & M. Schirmer. (2009) Aktuelle Therapieansätze bei RiesenzellarteriitisCurrent therapeutic options for giant cell arteritis. Zeitschrift für Rheumatologie 68:2, pages 132-136.
Crossref
Crossref
P. Duhaut. (2008) Maladie de Horton et pseudopolyarthrite rhizomélique : nouveautés thérapeutiques ? Évolution et pronostic. La Revue de Médecine Interne 29, pages S281-S285.
Crossref
Crossref
Valérie Devauchelle-Pensec, Sandrine Jousse, Claire Destombe & Alain Saraux. (2008) Epidémiologie, imagerie et traitement de la maladie de Horton. Revue du Rhumatisme 75:5, pages 392-397.
Crossref
Crossref
Valérie Devauchelle-Pensec, Sandrine Jousse, Claire Destombe & Alain Saraux. (2008) Epidemiology, imaging, and treatment of giant cell arteritis. Joint Bone Spine 75:3, pages 267-272.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Rheumatology 20:1, pages 111-120.
Crossref
Crossref
. (2007) Current World Literature. Current Opinion in Ophthalmology 18:6, pages 515-523.
Crossref
Crossref
Alexander FJE Vrancken, Richard AC Hughes, Gérard Said, John HJ Wokke & Nicolette C Notermans. (2007) Immunosuppressive treatment for non-systemic vasculitic neuropathy. Cochrane Database of Systematic Reviews.
Crossref
Crossref